Catalyst Wire Dossier Catalyst Wire Dossier

BI 187004 Tablet

BI 187004 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 187004 Tablet, covering 2016-01-27 to 2016-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers [Phase 1]

See pricing